Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial

Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial

Abstract Background Remimazolam tosilate (RT) is a novel short-acting GABA (A) receptor agonist that has a rapid recovery from procedural sedation and can be fully reversed by flumazenil. To date, there have been relatively few articles comparing RT and propofol for general anesthesia. This study ai...

Full description

Bibliographic Details
Main Authors: Wenchen Luo, Minli Sun, Jie Wan, Zhenyu Zhang, Jian Huang, Jinlin Zhang, Wanxia Xiong, Lirong Xia, Peiyao Xu, Changhong Miao, Xuesong Zhang, Mingyue Liu, Jing Zhong
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Anesthesiology
Subjects:
Remimazolam tosilate
Propofol
Flumazenil
General anesthesia
Day surgery
Online Access:https://doi.org/10.1186/s12871-023-02092-2

Internet

https://doi.org/10.1186/s12871-023-02092-2

Similar Items